Breaking Dermatology Literature: A Probiotic for AD, A JAK Inhibitor for Pemphigoid & IL-23 Inhibitors for Guttate Psoriasis
Description
Get ahead of the curve with Derms on Drugs as we break down the most exciting new dermatology research! This week features game-changing studies including an oral probiotic with stunning results for atopic dermatitis, JAK inhibitors for bullous pemphigoid, and IL-23 inhibitors tackling guttate psoriasis.
Plus, we dive deep into:
Dermoscopy advances for managing longitudinal melanonychia
If failing an IL-13 inhibitor affects the chances of doing well on another IL-13 inhibitor
New data on IL-13 inhibitor induced conjunctivitis
Red light PDT efficacy for superficial basal cell carcinoma
Early systemic PDE4 inhibition strategies in psoriasis
Follicular event insights from tapinarof studies
PDE4 inhibition potential for vitiligo treatment
Perfect for dermatology providers who want cutting-edge clinical pearls they can apply immediately. Tune in for evidence-based insights, practical takeaways, and the signature Derms on Drugs commentary that keeps you engaged while staying current.
See more at ScholarsInMedicine.com
United States
